Security key
G7709Q104
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)
CUSIP: G7709Q104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 424,966,351
- Total 13F shares
- 327,857,254
- Share change
- -14,283,438
- Total reported value
- $11,565,432,295
- Put/Call ratio
- 20%
- Price per share
- $35.28
- Number of holders
- 484
- Value change
- -$513,196,140
- Number of buys
- 292
- Number of sells
- 183
Report period
Q3 2025
Institutions
484
Top holders
10
RPRX full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Royalty Pharma plc SEC filings
Royalty Pharma plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP G7709Q104
Recent filing periods:
Top shareholders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Pablo G. Legorreta |
13D/G
|
Legorreta G. Pablo |
20%
|
103,112,796
|
$3,372,819,557 | $0 | 16 May 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
9.2%
from 13D/G
|
46,604,103
|
$1,679,145,924 | — | 30 Jun 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
6.5%
from 13D/G
|
40,357,821
|
$1,454,092,272 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.7%
from 13D/G
|
25,428,856
|
$916,201,678 | — | 30 Jun 2025 | |
| GENERAL ATLANTIC, L.P. |
13D/G
13F
|
Company |
3.2%
|
14,243,870
|
$510,500,301 | $0 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
2.5%
from 13D/G
|
36,377,678
|
$1,310,687,739 | — | 30 Jun 2025 | |
| Henry A. Fernandez |
3/4/5
|
Director |
0.03%
|
123,524
|
$4,190,575 | — | 30 Jun 2025 | |
| Vlad Coric |
3/4/5
|
Director |
0%
|
10,798
|
$344,996 | — | 13 May 2025 | |
| Attached Carole Ho |
3/4/5
|
Director |
0%
|
8,558
|
$306,718 | — | 31 Jul 2025 | |
| Elizabeth H. Weatherman |
3/4/5
|
Director |
0%
|
8,558
|
$306,718 | — | 31 Jul 2025 | |
| Capital International Investors |
13F
|
Company |
5.1%
|
21,880,620
|
$788,358,739 | — | 30 Jun 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
4.2%
|
18,020,455
|
$649,276,993 | — | 30 Jun 2025 | |
| Swedbank AB |
13F
|
Company |
2.9%
|
12,157,470
|
$438,033,645 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
10,194,938
|
$367,323,616 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
8,176,504
|
$299,493,652 | — | 30 Jun 2025 | |
| Caledonia (Private) Investments Pty Ltd |
13F
|
Company |
1.5%
|
6,444,729
|
$232,203,586 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
6,000,000
|
$216,180,000 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
1.2%
|
5,034,369
|
$181,388,315 | — | 30 Jun 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
4,491,680
|
$161,835,230 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.96%
|
4,076,999
|
$146,894,274 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.95%
|
4,021,850
|
$144,907,255 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.71%
|
3,008,837
|
$108,408,397 | — | 30 Jun 2025 | |
| Patient Capital Management, LLC |
13F
|
Company |
0.7%
|
2,987,988
|
$107,657,202 | — | 30 Jun 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.7%
|
2,976,480
|
$107,242,574 | — | 30 Jun 2025 | |
| NEW SOUTH CAPITAL MANAGEMENT INC |
13F
|
Company |
0.68%
|
2,886,569
|
$104,003,081 | — | 30 Jun 2025 | |
| Amundi |
13F
|
Individual |
0.66%
|
2,797,471
|
$101,240,476 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.64%
|
2,719,093
|
$97,968,916 | — | 30 Jun 2025 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.61%
|
2,597,460
|
$93,586,484 | — | 30 Jun 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.58%
|
2,470,706
|
$89,019,537 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.52%
|
2,206,765
|
$79,509,744 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.48%
|
2,041,344
|
$73,549,636 | — | 30 Jun 2025 | |
| HOMESTEAD ADVISERS CORP |
13F
|
Company |
0.46%
|
1,939,440
|
$69,878,023 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.45%
|
1,894,992
|
$68,271,502 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.41%
|
1,751,252
|
$63,097,609 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.41%
|
1,736,275
|
$62,149,952 | — | 30 Jun 2025 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.4%
|
1,717,588
|
$61,884,696 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.37%
|
1,559,378
|
$56,184,390 | — | 30 Jun 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.34%
|
1,454,200
|
$52,394,826 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.33%
|
1,413,512
|
$50,928,858 | — | 30 Jun 2025 | |
| Regal Partners Ltd |
13F
|
Company |
0.32%
|
1,345,196
|
$48,467,412 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
1,321,996
|
$47,631,508 | — | 30 Jun 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.31%
|
1,307,264
|
$47,071,645 | — | 30 Jun 2025 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.3%
|
1,260,205
|
$45,405,186 | — | 30 Jun 2025 | |
| WEDGE CAPITAL MANAGEMENT L L P/NC |
13F
|
Company |
0.29%
|
1,214,921
|
$43,773,604 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.26%
|
1,124,088
|
$40,500,870 | — | 30 Jun 2025 | |
| Swiss National Bank |
13F
|
Company |
0.26%
|
1,115,200
|
$40,180,656 | — | 30 Jun 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.26%
|
1,104,044
|
$39,778,791 | — | 30 Jun 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.23%
|
958,089
|
$34,520,000 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.22%
|
934,222
|
$33,660,019 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.22%
|
930,666
|
$33,531,896 | — | 30 Jun 2025 |
Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q3 2025
As of 30 Sep 2025,
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by
484 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
327,857,254 shares.
The largest 10 holders included
MORGAN STANLEY, FMR LLC, Capital International Investors, BlackRock, Inc., BAILLIE GIFFORD & CO, Swedbank AB, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
485
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
452
Q3 2025 holders
484
Holder diff
32
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.